P/E ratio for MeiraGTx (MGTX)
P/E ratio as of May 2024 (TTM): -1.95
According to MeiraGTx's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.95312. At the end of 2022 the company had a P/E ratio of -2.27.
P/E ratio history for MeiraGTx from 2018 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -2.27 | -82.68% |
| 2021 | -13.1 | 33.41% |
| 2020 | -9.83 | -17.99% |
| 2019 | -12.0 | 408.36% |
| 2018 | -2.36 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -0.5000 | -74.40% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -2.69 | 37.91% | 🇬🇧 UK |
 Novavax NVAX | -0.6857 | -64.89% | 🇺🇸 USA |
 Novocure
NVCR | -7.95 | 306.85% | Jersey |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.